Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: A Study of the Absorption, Distribution, Metabolism, and Elimination of Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-008) [Phase 1]
A Phase 1 trial evaluating the absorption, distribution, metabolism, and elimination of Opevesostat (MK-5684) in healthy adult male particip…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer [Phase 1]
Phase 1 study evaluating rh PSMA-7.3 PET/MRI as an imaging agent to detect recurrent prostate cancer and assist in radiotherapy planning; th…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Stockholm3 Validation Study in a Multi-Ethnic Cohort
Update on the Stockholm3 validation study in a multi-ethnic cohort assessing the performance of the Stockholm3 biomarker test for prostate c…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: PK and Dose Escalation and Expansion Study of DST-2970 [Phase 1]
Phase 1 PK and dose-escalation/expansion study of DST-2970 in prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Checkpoint Inhibitors and SBRT for MCRPC [Phase 2]
A Phase 2 trial evaluating checkpoint inhibitors in combination with stereotactic body radiotherapy for metastatic castration-resistant pros…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene Mutations [Phase 2]
This is a Phase 2 clinical trial update for Rucaparib in patients with metastatic hormone-sensitive prostate cancer harboring germline DNA r…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery [Phase 2]
This Phase 2 trial evaluates adding enzalutamide to salvage radiotherapy in men with recurrent prostate cancer after prostatectomy, to see i…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: 68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer [Phase 2]
This update reports Phase 2 results for the diagnostic imaging agent 68Ga-PSMA-11 PET in diagnosing metastatic castration-resistant prostate…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Early Staged Consent Before Prostate Biopsy [NA]
A clinical trial update describes early staged consent before prostate biopsy. The MSKCC-sponsored study (NCT03507725) has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Threedimensional Multiparametric Ultrasound for Prostate Cancer Detection
The clinical trial evaluating three-dimensional multiparametric ultrasound for detecting prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011) [Phase 1]
Phase 1 drug-drug interaction study evaluating diltiazem with MK-5684 in healthy adult male participants has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer [Phase 1]
Phase 1 trial evaluating IL-12 gene therapy for locally recurrent prostate cancer has completed, with results posted in October 2024.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer [Phase 3]
An open-label Phase 3 trial evaluating Sipuleucel-T in active surveillance patients with newly diagnosed prostate cancer has completed. The …
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Shared Decision Making: Prostate Cancer Screening [NA]
A completed clinical trial update on shared decision making for prostate cancer screening.
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: Diet Effect on Cancer Treatment Outcome [Phase 1]
A Phase 1 clinical trial evaluating the impact of diet on cancer treatment outcomes in breast and prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: Efficacy of a Couple-Focused mHealth Symptom Self-management Program [NA]
This clinical trial update reports on the efficacy of a couple-focused mobile health symptom self-management program for prostate cancer. Th…
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: Androgen Deprivation Therapy Prior to Prostatectomy for Patients with Intermediate and High Risk Prostate Cancer [NA]
This clinical trial investigated androgen deprivation therapy before prostatectomy in men with intermediate- and high-risk prostate cancer; …
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer [Phase 1, Phase 2]
Results from a Phase 1/2 clinical trial of the radiolabeled imaging agent 89Zr-DFO-MSTP2109A in prostate cancer have been posted; the study …
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: 64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA) [Phase 1, Phase 2]
Phase 1/2 trial of 64Cu-SAR-bisPSMA for identifying recurrence of prostate cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer [NA]
This completed trial evaluated CyberKnife-based radiotherapy as monotherapy or as a boost with SBRT for intermediate- to high-risk localized…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: FIRMAGON® Intensive Drug Monitoring
Results from an intensive drug monitoring study of FIRMAGON (degarelix) in prostate cancer have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway [Phase 1]
This clinical trial update describes a Phase 1 study of the PARP inhibitor DAT-2645 monotherapy for advanced/metastatic solid tumors harbori…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Addition of Opaganib to Androgen Antagonists in Patients With mCRPC [Phase 2]
Phase 2 trial results evaluating the addition of opaganib to androgen antagonists in patients with metastatic castration-resistant prostate …
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 bioequivalence study comparing the proposed talazoparib capsule formulation to the current formulation, plus a food-effect assessmen…
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: A Study of Patients Receiving High-Dose Rate Brachytherapy [Phase 2]
A Phase 2 study of high-dose-rate brachytherapy in patients with cervical cancer, endometrial cancer, esophageal cancer, prostate cancer, an…